Empower Advisory Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Empower Advisory Group's EW Position: Q3 2026 in Review
Empower Advisory Group increased its Edwards Lifesciences (EW) stake by 1.8% in Q3 2026, buying an estimated $1.41M and bringing the position to 904,521 shares worth $78.1M. The position accounts for 0.18% of the portfolio, ranked #107.
Empower Advisory Group first reported a position in EW in Q1 2023 and has held it in 15 quarters since. The position peaked at $80.4M in Q2 2026. 1,339 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Empower Advisory Group held 904,521 shares of Edwards Lifesciences worth $78.1M as of Q3 2026.
- Empower Advisory Group bought 15,901 Edwards Lifesciences shares in Q3 2026, an estimated $1.41M.
- Edwards Lifesciences made up 0.18% of Empower Advisory Group's portfolio in Q3 2026, its #107 holding.
- Empower Advisory Group first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 15 quarters since.
- Empower Advisory Group's Edwards Lifesciences position peaked at $80.4M in Q2 2026.
- 1,339 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Empower Advisory Group's 13F filing for Q3 2026, filed 13 Nov 2026.